Skip to content

Supplier News

Horizon adds gout drug with Crealta acquisition

Horizon adds gout drug with Crealta acquisition

Horizon Pharma plc plans to acquire Crealta Holdings LLC for $510 million in cash. Horizon said the deal will bring the company Krystexxa (pegloticase), the first and only Food and Drug Administration-approved drug for chronic refractory gout.

Takeda’s Ninlaro becomes available in U.S.

Takeda’s Ninlaro becomes available in U.S.

Takeda Pharmaceutical Co. has released Ninlaro capsules (ixazomib), a blood cancer medication, in the United States. Takeda said Friday that Ninlaro is the first and only oral proteasome inhibitor.

Jelly Belly to expand Star Wars lineup

Jelly Belly to expand Star Wars lineup

Jelly Belly Candy Co. has a way for the Force to be with retailers. For the debut of the major motion picture “Star Wars: The Force Awakens” on Dec. 18, the candy maker next month plans to release two new products for its Star Wars Collection of gifts: the 8.5-oz. “Star Wars: The Force Awakens”

Amneal starts rollout of lidocaine product line

Amneal starts rollout of lidocaine product line

Amneal Pharmaceuticals LLC has begun shipping lidocaine 5% ointment to lead off the launch of a new lidocaine product line. Amneal said late Tuesday that its lidocaine 5% ointment is available in a 35.44-g tube with child-resistant cap and in a 50-g jar.

Camber launches generic version of Prozac

Camber launches generic version of Prozac

Camber Pharmaceuticals has released fluoxetine capsules, an antidepressant, and losartan potassium, a hypertension medication. Camber said Tuesday that its fluoxetine capsules are available in strengths of 10 mg, 20 mg, 40 mg in both 30 and 100-count bottles.

Schweppes rolls out dark ginger ale

Schweppes rolls out dark ginger ale

With the onset of the holiday season, Schweppes has introduced the new Schweppes Dark Ginger Ale to give consumers more ginger taste. The Dr. Pepper Snapple Group brand said Monday that Schweppes Dark Ginger Ale taps into the rising demand for stronger flavors.

EcoTools unveils holiday brush sets

EcoTools unveils holiday brush sets

EcoTools is featuring three limited-edition holiday makeup brush sets in a new online videos as part of its “Looks You Love” series. The beauty care accessories company said Monday that the video tutorials introduce new makeup and hair looks for the holidays developed by the EcoTools Beauty Team.

BIOTA Botanicals launches new website

BIOTA Botanicals launches new website

BIOTA Botanicals has launched a new website for its U.S. customers, BiotaUSA.com. Content on the new site spotlights the BIOTA Botanicals Advanced Herbal Care and BIOTA Botanicals Proactive Herbal Care brands, hair care tips and where-to-buy information.

Keurig Green Mountain to go private in buyout

Keurig Green Mountain to go private in buyout

Keurig Green Mountain Inc. is slated to go private in a $13.9 billion buyout deal by a JAB Holding Co.-led investor group. The companies said Monday that the investor group plans to acquire Keurig Green Mountain for $92 per share in cash, which represents a premium of 77.9% over the coffee giant’s

Heritage releases Calan generic

Heritage releases Calan generic

Heritage Pharmaceuticals Inc. has rolled verapamil 40-mg immediate-release tablets, a calcium channel blocker medication. Heritage said that its verapamil product is a generic version of Pfizer Inc.’s Calan, indicated for the treatment of angina, arrhythmias and hypertension.

PharmaSmart, Astrup Drug partner in BP pilot

PharmaSmart, Astrup Drug partner in BP pilot

Blood pressure kiosk maker PharmaSmart took part in a pilot with Astrup Drug’s Sterling Pharmacy and nonprofit health group HealthPartners to show the potential of community pharmacists in helping patients with hypertension.

Pfizer to acquire Allergan for $160 billion

Pfizer to acquire Allergan for $160 billion

Pfizer Inc. plans to acquire Allergan Inc. for about $160 billion in the biggest deal ever in the health care sector. Pfizer said Monday that the transaction will allow the New York-based drug giant to relocate to Ireland to cut its U.S. tax burden. “The proposed combination of Pfizer

AmerisourceBergen’s Collis to become chairman

AmerisourceBergen’s Collis to become chairman

Steven Collis, president and chief executive officer of AmerisourceBergen Corp., has been named to succeed Richard Gozon as chairman. The company said Wednesday that Collis is slated to become chairman upon Gozon’s retirement at AmerisourceBergen’s annual shareholders meeting on March 3, 2016.